10x Genomics to Showcase Innovations at J.P. Morgan Healthcare Conference 2026
10x Genomics at the J.P. Morgan Healthcare Conference 2026
10x Genomics, Inc. (Nasdaq: TXG), recognized as a leader in the fields of single cell and spatial biology, is gearing up for a significant appearance at the 44th Annual J.P. Morgan Healthcare Conference. Scheduled for January 12, 2026, at 8:15 a.m. Pacific Time, this presentation will showcase the company's innovative advancements in life sciences technology.
The management team plans to provide a detailed overview of 10x Genomics' pioneering approach to understanding biological systems, which has been a cornerstone of the company’s mission to enhance human health. Attendees will gain insights into their integrated solutions that include advanced instruments, consumables, and software designed for single cell and spatial biology research. These tools empower academic and translational researchers, as well as biopharmaceutical companies, to deepen their comprehension of complex biological systems.
At the J.P. Morgan Healthcare Conference, participants will also have the opportunity to engage in a live webcast of the management team's presentation, which will be accessible via the